Related Experiment Video

Updated: Aug 24, 2026

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

Simvastatin reduces interleukin-1beta secretion by peripheral blood mononuclear cells in patients with essential

Shuiping Zhao1, Quanzhong Li, Ling Liu

  • 1Department of Cardiology, The Second Xiangya Hospital, Central South University, 86# Renmin Middle Road, Changsha, Hunan 410011, PR China. ZhaoSP@medmail.com.cn

Clinica Chimica Acta; International Journal of Clinical Chemistry
|May 20, 2004
PubMed

Insights

Essential hypertension is linked to higher interleukin-1beta (IL-1beta) secretion from immune cells. Simvastatin treatment significantly reduced this IL-1beta secretion, suggesting a potential anti-inflammatory benefit in hypertension.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Pharmacology

Background:

  • Essential hypertension (EH) is associated with chronic low-grade inflammation, a risk factor for atherosclerosis.
  • Interleukin-1beta (IL-1beta) is a key inflammatory cytokine implicated in cardiovascular disease.
  • Statins, including simvastatin, possess anti-inflammatory properties that may benefit patients with hypertension.

Purpose of the Study:

  • To investigate elevated IL-1beta secretion in peripheral blood mononuclear cells (PBMCs) of individuals with essential hypertension.
  • To determine if simvastatin treatment can reduce IL-1beta secretion by PBMCs in patients with essential hypertension.

Main Methods:

  • PBMCs were isolated from 24 EH patients and 12 normotensive controls.
  • IL-1beta secretion was measured using ELISA after stimulation with angiotensin II.
  • EH patients were randomized to valsartan alone or valsartan plus simvastatin for one week.

Main Results:

  • Patients with EH exhibited significantly higher IL-1beta secretion from PBMCs compared to controls.
  • Simvastatin treatment led to a significant reduction in IL-1beta secretion by PBMCs.
  • The observed reduction in IL-1beta secretion was independent of changes in plasma lipid levels.

Conclusions:

  • Essential hypertension is characterized by increased PBMC activation, indicated by elevated IL-1beta secretion.
  • Simvastatin treatment may partially mitigate this inflammatory abnormality in essential hypertension.
  • These findings suggest a potential role for simvastatin in managing inflammation associated with hypertension.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...